Phase 3b WAYFINDER data show tezepelumab oral corticosteroid reduction in severe asthma, with nearly 90 percent reaching 5 mg ...

Please provide your email address to receive an email when new articles are posted on . Weekly use of household disinfectants and cleaning products was associated with current asthma. Risks for ...

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...

Around 88% of primary care providers managing patients with uncontrolled asthma reported being unfamiliar or only somewhat ...

The injection is recommended as an additional maintenance treatment for patients over 12 when usual medications have not proven effective enough ...

One poster found patients with uncontrolled asthma had improved outcomes after escalating to triple therapy, while the other found a substantial portion of patients adherent to a dual therapy reported ...

Tezepelumab reduced exacerbations across all seasons in severe uncontrolled asthma, even among patients with perennial and seasonal allergies.

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

"Regardless of the insurance and of their access to prescription treatment, there are considerable risks associated with being a member of a racial and ethnic community, and increased risk of ...

ARLINGTON HEIGHTS, IL (Feb. 2, 2021) - As the number of states increase where medical and recreational cannabis use is legal, so does the importance that physicians discuss with patients the effects ...